Chen Anjie, Li Sixin, Gui Jiandong, Zhou Hangsheng, Zhu Lijie, Mi Yuanyuan
Department of Urology, Affiliated Hospital of Jiangnan University, 1000 Hefeng Road, Wuxi, 214122, Jiangsu Province, China.
Wuxi School of Medicine, Jiangnan University, 1800 Lihudadao, Wuxi, 214122, Jiangsu Province, China.
Heliyon. 2024 Aug 2;10(15):e35723. doi: 10.1016/j.heliyon.2024.e35723. eCollection 2024 Aug 15.
Tropomyosin (TPM) is an important regulatory protein that binds to actin in fine myofilaments, playing a crucial role in the regulation of muscle contraction. TPM3, as one of four tropomyosin genes, is notably prevalent in eukaryotic cells. Traditionally, abnormal gene expression of TPM3 has been exclusively associated with myopathy. However, recent years have witnessed a surge in studies highlighting the close correlation between abnormal expression of TPM3 and the onset, progression, metastasis, and prognosis of various malignant tumors. In light of this, investigating the mechanisms underlying the pathogenetic role of TPM3 holds significant promise for early diagnosis and more effective treatment strategies. This article aims to provide an insightful review of the structural characteristics of TPM3 and its intricate role in the occurrence and development of malignant tumors.
原肌球蛋白(TPM)是一种重要的调节蛋白,它与细肌丝中的肌动蛋白结合,在肌肉收缩调节中起关键作用。TPM3作为四个原肌球蛋白基因之一,在真核细胞中显著普遍存在。传统上,TPM3的基因异常表达仅与肌病相关。然而,近年来,越来越多的研究强调了TPM3异常表达与各种恶性肿瘤的发生、发展、转移和预后之间的密切相关性。鉴于此,研究TPM3致病作用的潜在机制对于早期诊断和更有效的治疗策略具有重要意义。本文旨在对TPM3的结构特征及其在恶性肿瘤发生发展中的复杂作用进行深入综述。